SUCCESSFUL RE-TREATMENT WITH AZACITIDINE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS) EVOLUTED INTO ACUTE MYELOID LEUKEMIA (AML) AFTER THE SUSPENSION OF THIS AGENT

被引：0
|
作者：
Niscola, P. [1 ]
Tendas, A. [1 ]
Cupelli, L. [1 ]
Scaramucci, L. [1 ]
Giovannini, M. [1 ]
Fratoni, S. [2 ]
de Fabritiis, P. [2 ]
机构：
[1] S Eugenio Hosp, Hematol, Rome, Italy
[2] S Eugenio Hosp, Dept Pathol, Rome, Italy
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：S137 / S138
页数：3
相关论文
共 50 条
  • [1] Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
    Niscola, Pasquale
    Tendas, Andrea
    Scaramucci, Laura
    Giovannini, Marco
    Fratoni, Stefano
    de Fabritiis, Paolo
    BLOOD RESEARCH, 2015, 50 (02) : 113 - 114
  • [2] SUCCESSFUL RETREATMENT WITH AZACITIDINE OF A PATIENT WITH ACUTE MYELOID LEUKEMIA TRANSFORMED FROM MYELODYSPLASTIC SYNDROME AFTER THE SUSPENSION OF THIS AGENT
    Niscola, P.
    Piccioni, D.
    Tendas, A.
    Cupelli, L.
    Scaramucci, L.
    Giovannini, M.
    Fratoni, S.
    de Fabritiis, P.
    HAEMATOLOGICA, 2015, 100 : 103 - 103
  • [3] Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer
    Gupta, B.
    Sait, S. N.
    Block, A. W.
    Ford, L. A.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ault, Patricia S.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan H.
    Jabbour, Elias J.
    Cleeland, Charles S.
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [5] Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    BLOOD, 2010, 116 (21) : 199 - 199
  • [6] ASSESSMENT OF INFECTION EVENTS IN AZACITIDINE (AZA) TREATMENT FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML). A SINGLE CENTRE EXPERIENCE.
    Romero, P.
    Borras, J. B.
    Serra, F.
    Nigorra, M.
    Del Campo, R.
    Cladera, A.
    Vazquez, I.
    Mascaro, M.
    Gonzalez, E.
    Guerra, J. M.
    Gomez, D.
    Bargay, J.
    HAEMATOLOGICA, 2014, 99 : 196 - 196
  • [7] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [8] BASOPHILIA IN PATIENTS WITH MYELODYSPLASIC SYNDROME (MDS)/ACUTE MYELOID LEUKEMIA (AML) WHO RESPOND TO TREATMENT WITH AZACITIDINE
    Calderon Lopez, M. T.
    Garcia Leon, N.
    Seri Merino, C.
    Sandoval Barreto, E.
    Otero Martinez, M. J.
    Matilla Garcia, A.
    HAEMATOLOGICA, 2019, 104 : 439 - 440
  • [9] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
    Mast, K.
    Taub, J. W.
    Alonzo, T.
    Mosse, C.
    Gamis, A. S.
    Mathew, P.
    Jones, H.
    Hitzler, J.
    Head, D. R.
    LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
  • [10] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
12345